HOME >> MEDICINE >> NEWS
Data supports extremely early intervention for multiple sclerosis patients

MILAN, ITALY, September 20, 2003 Immediate initiation of drug treatment with Avonex in individuals considered at risk to develop multiple sclerosis (MS) continues to slow the development of MS after five years compared to initiation of therapy more than two years after the onset of symptoms, according to data being presented today at the meeting of the European Committee for Treatment and Research in MS (ECTRIMS).

The findings by principal investigator R. Philip Kinkel, M.D., director of the Multiple Sclerosis Center at Beth Israel Deaconess Medical Center in Boston, are the result of a clinical trial known as Controlled High Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance (CHAMPIONS), the longest study among MS patients followed from the onset of symptoms. The study was sponsored by Biogen, Inc., maker of Avonex (interferon beta-1a).

"Multiple sclerosis is the most common disabling illness affecting young adults, generally striking between ages 20 and 40," says Kinkel, who is also Associate Professor of Neurology at Harvard Medical School. A chronic disease of the central nervous system, MS affects nearly 1 million individuals worldwide. "Being able to initiate very early treatment could significantly delay the onset of severe neurological symptoms including loss of vision, mobility and cognitive ability in this young population."

One of the primary problems in diagnosing multiple sclerosis, explains Kinkel, is that the disease nearly escapes notice in its earliest stages. "The initial symptoms of MS are often non-specific [pins and needles sensations in a limb, electrical sensations, non-specific dizziness or extreme fatigue], suddenly appearing and then disappearing within a short period of time, only to recur and become obvious much later after the disease has already spread throughout the nervous system." To make matters worse, not all patients who experience definite MS-like symptoms from the ons
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
20-Sep-2003


Page: 1 2 3

Related medicine news :

1. Emergency department study supports giving dehydrated children fluids by mouth
2. Review supports link between HRT and stroke
3. Chamomile tea: New evidence supports health benefits
4. Social supports lessen effects of maltreatment on children vulnerable to depression
5. Study supports the use of mechanical assistance
6. Study supports aggressive treatment of heart patients with cholesterol-lowering medication
7. New data supports CellCepts position as a world leader in solid organ transplantation
8. NCI grant supports Jefferson trial to study test for colorectal cancer recurrence
9. Study supports new theory for nicotines protective effect against neurodegenerative disorders
10. New study supports use of PET scans in early diagnosis of Alzheimers disease
11. Contraception study supports convenience, simplicity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: